Cholesterol drug not linked to cancer
(Reuters)
Reuters - Contrary to a recent report, findings from a large-scale study suggest that the cholesterol-lowering drug Zetia (also known by the generic name, ezetimibe) does not increase the risk of cancer. This also holds true for Vytorin, which combines ezetimibe with simvastatin, another cholesterol-lowering agent.
http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20090327/hl_nm/us_health_cholesterol